Bioluminescence Ventures

Bioluminescence is a leading US biotechnology venture capital firm investing in the future of medicine. We are inspired by the accelerating pace of biomedical innovation and its recent impact on humanity. Bioluminescence Ventures was conceptualized to finance breakthrough platforms and support mission-driven leaders to develop first-in-class or best-in-class therapies for patients with major unmet medical needs. We are mission-driven – investing our time, energy, and capital into translating transformative science into next-generation medicines that will impact patients. We believe that, as long as we continue to succeed in this endeavor, then strong financial returns will follow. The firm focuses investments on four areas: Breakthrough Biology, Drug Discovery Platforms, Genetic Medicines Platforms, and Computational Biology Platforms.